{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T21:44:32Z","timestamp":1773697472995,"version":"3.50.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1097\/dss.0000000000000591","type":"journal-article","created":{"date-parts":[[2016,1,15]],"date-time":"2016-01-15T16:56:43Z","timestamp":1452877003000},"page":"141-146","source":"Crossref","is-referenced-by-count":38,"title":["A Review of the Association Between Parkinson Disease and Malignant Melanoma"],"prefix":"10.1097","volume":"42","author":[{"given":"Max","family":"Disse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilary","family":"Reich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah S.","family":"Schram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-1-20210206","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/archdermatol.2010.19","article-title":". Incidence estimate of nonmelanoma skin cancer in the United States, 2006.","volume":"146","author":"Rogers","year":"2010","journal-title":"Arch Dermatol"},{"key":"R2-1-20210206","doi-asserted-by":"crossref","first-page":"e10481","DOI":"10.1371\/journal.pone.0010481","article-title":"Parkinsons disease-related protein, -synuclein, in malignant melanoma.","volume":"5","author":"Matsuo","year":"2010","journal-title":"PLoS One"},{"key":"R4-1-20210206","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pneurobio.2005.02.001","article-title":". Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinsons disease.","volume":"75","author":"Fedorow","year":"2005","journal-title":"Prog Neurobiol"},{"key":"R6-1-20210206","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev-pathol-011110-130242","article-title":"Parkinsons disease: genetics and pathogenesis.","volume":"6","author":"Shulman","year":"2011","journal-title":"Ann Rev Pathol"},{"key":"R7-1-20210206","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/jama.1978.03290060056015","article-title":"Levodopa therapy and malignant melanoma.","volume":"240","author":"Sober","year":"1978","journal-title":"JAMA"},{"key":"R9-1-20210206","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/mds.21575","article-title":". Skin cancers and precancerous lesions in Parkinsons disease patients.","volume":"22","author":"Ferreira","year":"2007","journal-title":"Mov Disord"},{"key":"R10-1-20210206","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.parkreldis.2009.05.002","article-title":"Parkinsons disease, levodopa-use and the risk of melanoma.","volume":"15","author":"Vermeij","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"R11-1-20210206","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1212\/WNL.0b013e31821e554e","article-title":"Meta-analysis of the relationship between Parkinson disease and melanoma.","volume":"76","author":"Liu","year":"2011","journal-title":"Neurology"},{"key":"R12-1-20210206","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/sj.bjc.6602279","article-title":". Atypical cancer pattern in patients with Parkinsons disease.","volume":"92","author":"Olsen","year":"2004","journal-title":"Br J Cancer"},{"key":"R13-1-20210206","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/mds.22855","article-title":". Skin cancer and Parkinsons disease.","volume":"25","author":"Ferreira","year":"2010","journal-title":"Mov Disord"},{"key":"R14-1-20210206","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/archneurol.2010.1","article-title":". Increased melanoma risk in Parkinson disease: a prospective clinicopathological study.","volume":"67","author":"Bertoni","year":"2010","journal-title":"Arch Neurol"},{"key":"R15-1-20210206","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s10552-009-9497-6","article-title":"Parkinsons disease and cancer risk: a systematic review and meta-analysis.","volume":"21","author":"Bajaj","year":"2010","journal-title":"Cancer Causes Control"},{"key":"R16-1-20210206","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.ede.0000229445.90471.5e","article-title":"Malignant melanoma and other types of cancer preceding Parkinson disease.","volume":"17","author":"Olsen","year":"2006","journal-title":"Epidemiology"},{"key":"R17-1-20210206","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1212\/WNL.0b013e3181bd13a1","article-title":". Family history of melanoma and Parkinson disease risk.","volume":"73","author":"Gao","year":"2009","journal-title":"Neurology"},{"key":"R18-1-20210206","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/aje\/kwt232","article-title":". Parkinsons disease and cancer: a register-based family study.","volume":"179","author":"Wirdefeldt","year":"2014","journal-title":"Am J Epidemiol"},{"key":"R19-1-20210206","first-page":"219","article-title":". -synuclein multimers cluster synaptic vesicles and attenuate recycling.","volume":"19","author":"Wang","year":"2014","journal-title":"Curr Biol"},{"key":"R20-1-20210206","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neulet.2010.09.061","article-title":"Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo.","volume":"486","author":"Chinta","year":"2010","journal-title":"Neurosci Lett"},{"key":"R21-1-20210206","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1750-1326-6-6","article-title":"Leucine-rich repeat kinase 2 and alpha-synuclein: intersecting pathways in the pathogenesis of Parkinsons disease.","volume":"6","author":"Greggio","year":"2011","journal-title":"Mol Neurodegener"},{"key":"R22-1-20210206","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/mds.25292","article-title":". The current and projected economic burden of Parkinsons disease in the United States.","volume":"28","author":"Kowal","year":"2013","journal-title":"Mov Disord"},{"key":"R23-1-20210206","doi-asserted-by":"crossref","first-page":"e45183","DOI":"10.1371\/journal.pone.0045183","article-title":"The role of alpha-synuclein in melanin synthesis in melanoma and dopaminergic neuronal cells.","volume":"7","author":"Pan","year":"2012","journal-title":"PLoS One"},{"key":"R24-1-20210206","doi-asserted-by":"crossref","first-page":"a009357","DOI":"10.1101\/cshperspect.a009357","article-title":". The role of autophagy in Parkinsons disease.","volume":"2","author":"Lynch-Day","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R27-1-20210206","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1750-1326-7-42","article-title":". Exosomal cell-to-cell transmission of alpha synuclein oligomers.","volume":"7","author":"Danzer","year":"2012","journal-title":"Mol Neurodegener"},{"key":"R28-1-20210206","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ana.20904","article-title":". Pesticide exposure and risk for Parkinsons disease.","volume":"60","author":"Ascherio","year":"2006","journal-title":"Ann Neurol"},{"key":"R29-1-20210206","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1002\/ijc.25503","article-title":". Plasma levels of polychlorinated biphenyls and risk of cutaneous malignant melanoma: a preliminary study.","volume":"128","author":"Gallagher","year":"2011","journal-title":"Int J Cancer"},{"key":"R30-1-20210206","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/toxsci\/kft076","article-title":". Specific pesticide-dependent increases in alpha-synuclein levels in human neuroblastoma (SH-SY5Y) and melanoma (SK-MEL-2) cell lines.","volume":"133","author":"Chorfa","year":"2013","journal-title":"Toxicol Sci"},{"key":"R31-1-20210206","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.mehy.2008.10.011","article-title":"Pigmentation genes link Parkinsons disease to melanoma, opening a window on both etiologies.","volume":"72","author":"Herrero Hernandez","year":"2009","journal-title":"Med Hypotheses"},{"key":"R32-1-20210206","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12640-013-9435-y","article-title":". Neuromelanin of the human substantia nigra: an update.","volume":"25","author":"Zucca","year":"2014","journal-title":"Neurotox Res"},{"key":"R33-1-20210206","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.abb.2014.07.002","article-title":". Melanocortins and the melanocortin 1 receptor, moving translationally towards melanoma prevention.","volume":"563","author":"Abdel-Malek","year":"2014","journal-title":"Arch Biochem Biophys"},{"key":"R34-1-20210206","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/ana.21535","article-title":". Genetic determinants of hair color and Parkinsons disease risk.","volume":"65","author":"Gao","year":"2009","journal-title":"Ann Neurol"},{"key":"R35-1-20210206","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.mrrev.2010.06.002","article-title":"Genetics of pigmentation in skin cancera review.","volume":"705","author":"Scherer","year":"2010","journal-title":"Mutat Res"},{"key":"R36-1-20210206","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.abb.2014.07.003","article-title":"Cyclic AMP (cAMP) signaling in melanocytes and melanoma.","volume":"563","author":"Rodriguez","year":"2014","journal-title":"Arch Biochem Biophys"},{"key":"R37-1-20210206","doi-asserted-by":"crossref","first-page":"e101507","DOI":"10.1371\/journal.pone.0101507","article-title":". Development of a melanoma risk prediction model incorporating MC1R genotype and indoor tanning exposure: impact of mole phenotype on model performance.","volume":"9","author":"Penn","year":"2014","journal-title":"PLoS One"},{"key":"R38-1-20210206","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s12031-014-0425-1","article-title":". The melanocortin 1 receptor (Mc1r) variants do not account for the co-occurrence of Parkinsons disease and malignant melanoma.","volume":"54","author":"Elincx-Benizri","year":"2014","journal-title":"J Mol Neurosci"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000000591","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:26:05Z","timestamp":1620951965000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042728-201602000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000000591","relation":{},"ISSN":["1076-0512"],"issn-type":[{"value":"1076-0512","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]}}}